more general categories |
information about this item |
|
1. Human Genes |
 |
 |
|
1. Human Genes |
|
|
aldo-keto reductase family 1, member C1 [HGNC:AKR1C1] (148) |
|
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha [HGNC:NFKBIA] (290) |
|
|
CCAAT/enhancer binding protein (C/EBP), delta [HGNC:CEBPD] (51) |
|
|
FBJ murine osteosarcoma viral oncogene homolog [HGNC:FOS] (277) |
|
|
jun B proto-oncogene [HGNC:JUNB] (59) |
|
|
jun D proto-oncogene [HGNC:JUND] (61) |
|
|
chemokine (C-X-C motif) ligand 02 [HGNC:CXCL2] (65) |
|
|
|
|
|
lamin B1 [HGNC:LMNB1] (50) |
|
|
|
|
|
ubiquinol-cytochrome c reductase core protein II [HGNC:UQCRC2] (17) |
|
|
|
|
|
mitogen-activated protein kinase kinase 1 [HGNC:MAP2K1] (106) |
|
|
retinoic acid receptor, gamma [HGNC:RARG] (33) |
|
|
EWS RNA-binding protein 1 [HGNC:EWSR1] (14) |
|
|
FK506 binding protein 05 [HGNC:FKBP5] (46) |
|
 |
2. Interaction: Human Genes and Chemicals |
 |
 |
|
2. Interaction: Human Genes and Chemicals |
|
|
expression (494) |
|
|
expression (3238) |
|
 |
4. Semantic Terms |
 |
 |
|
4. Semantic Terms |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hazardous or Poisonous Substance [STY:T131] (590) |
|
|
Organic Chemical [STY:T109] (44144) |
|
 |
C02. Virus Diseases |
 |
 |
|
C02. Virus Diseases |
|
|
|
|
|
|
|
|
|
|
|
HIV Infections [MESH:D015658] (3402) |
|
|
|
|
|
HIV Infections [MESH:D015658] (3296) |
|
 |
C04. Neoplasms |
 |
 |
|
C04. Neoplasms |
|
|
Precancerous Conditions [MESH:D011230] (2858) |
|
|
|
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
|
|
|
|
|
|
Leukemia, Myeloid, Acute [MESH:D015470] (2176) |
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
|
Hepatoblastoma [MESH:D018197] (548) |
|
|
|
|
|
|
|
|
|
|
|
Sarcoma, Ewing [MESH:D012512] (79) |
|
|
|
|
|
Rhabdomyosarcoma [MESH:D012208] (789) |
|
|
Hemangiosarcoma [MESH:D006394] (1836) |
|
|
Rhabdomyosarcoma [MESH:D012208] (789) |
|
|
Sarcoma, Ewing [MESH:D012512] (79) |
|
|
|
|
|
|
|
|
Neuroectodermal Tumors, Primitive [MESH:D018242] (2005) |
|
|
Gliosarcoma [MESH:D018316] (880) |
|
|
Glioblastoma [MESH:D005909] (2554) |
|
|
Melanoma [MESH:D008545] (3508) |
|
|
|
|
|
Carcinoma, Squamous Cell [MESH:D002294] (4294) |
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
|
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Neuroectodermal Tumors, Primitive [MESH:D018242] (2005) |
|
|
Gliosarcoma [MESH:D018316] (880) |
|
|
Glioblastoma [MESH:D005909] (2554) |
|
|
Carcinoma, Squamous Cell [MESH:D002294] (4294) |
|
|
|
|
|
|
|
|
Neuroectodermal Tumors, Primitive [MESH:D018242] (2005) |
|
|
Gliosarcoma [MESH:D018316] (880) |
|
|
Glioblastoma [MESH:D005909] (2554) |
|
|
Melanoma [MESH:D008545] (3508) |
|
|
Hemangiosarcoma [MESH:D006394] (1836) |
|
|
Melanoma [MESH:D008545] (3508) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
Esophageal Neoplasms [MESH:D004938] (3737) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
|
|
|
Colonic Neoplasms [MESH:D003110] (4405) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Ovarian Neoplasms [MESH:D010051] (3275) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
Esophageal Neoplasms [MESH:D004938] (3737) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
|
|
|
Brain Neoplasms [MESH:D001932] (2764) |
|
|
|
|
|
|
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
|
|
|
|
|
|
Endometrial Neoplasms [MESH:D016889] (1987) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Kidney Neoplasms [MESH:D007680] (3966) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Mammary Neoplasms, Experimental [MESH:D008325] (3268) |
|
|
Neoplasm Invasiveness [MESH:D009361] (3388) |
|
|
Neoplasm Metastasis [MESH:D009362] (4441) |
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
 |
C05. Musculoskeletal Diseases |
 |
 |
|
C05. Musculoskeletal Diseases |
|
|
|
|
|
Bone Resorption [MESH:D001862] (2352) |
|
|
|
|
|
Fibrous Dysplasia of Bone [MESH:D005357] (737) |
|
|
Osteogenesis Imperfecta, Type IX [MESH:C564921] (46) |
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
Arthritis, Experimental [MESH:D001169] (3142) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
|
|
|
|
Costello Syndrome [MESH:D056685] (407) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
Osteoarthritis [MESH:D010003] (1743) |
|
 |
C06. Digestive System Diseases |
 |
 |
|
C06. Digestive System Diseases |
|
|
|
|
|
|
|
|
Cholestasis [MESH:D002779] (3419) |
|
|
|
|
|
Esophageal Neoplasms [MESH:D004938] (3737) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
|
|
|
Colonic Neoplasms [MESH:D003110] (4405) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
|
|
|
Esophageal Neoplasms [MESH:D004938] (3737) |
|
|
Esophageal Neoplasms [MESH:D004938] (3737) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
|
|
|
Colonic Neoplasms [MESH:D003110] (4405) |
|
|
|
|
|
|
|
|
Colonic Neoplasms [MESH:D003110] (4405) |
|
|
|
|
|
Colonic Neoplasms [MESH:D003110] (4405) |
|
|
Stomach Ulcer [MESH:D013276] (2915) |
|
|
Stomach Neoplasms [MESH:D013274] (4942) |
|
|
Stomach Ulcer [MESH:D013276] (2915) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Hypertension, Portal [MESH:D006975] (869) |
|
|
Liver Failure [MESH:D017093] (2768) |
|
|
Liver Cirrhosis, Experimental [MESH:D008106] (4589) |
|
|
Carcinoma, Hepatocellular [MESH:D006528] (5375) |
|
|
Liver Neoplasms, Experimental [MESH:D008114] (2837) |
|
|
|
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
 |
C07. Stomatognathic Diseases |
 |
 |
|
C07. Stomatognathic Diseases |
|
|
|
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
 |
C08. Respiratory Tract Diseases |
 |
 |
|
C08. Respiratory Tract Diseases |
|
|
|
|
|
Asthma [MESH:D001249] (4098) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Hypertension, Pulmonary [MESH:D006976] (2000) |
|
|
Lung Injury [MESH:D055370] (3688) |
|
|
Pulmonary Edema [MESH:D011654] (2109) |
|
|
Pulmonary Fibrosis [MESH:D011658] (3140) |
|
|
Asthma [MESH:D001249] (3903) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
|
Asthma [MESH:D001249] (4098) |
|
|
|
|
|
Bronchitis, Chronic [MESH:D029481] (569) |
|
|
|
|
|
Adenocarcinoma of lung [MESH:C538231] (1487) |
|
|
|
|
|
Carcinoma, Non-Small-Cell Lung [MESH:D002289] (3540) |
|
 |
C10. Nervous System Diseases |
 |
 |
|
C10. Nervous System Diseases |
|
|
Not Fully Specified [NFS] (4027) |
|
|
|
|
|
|
|
|
Brain Injuries [MESH:D001930] (3429) |
|
|
Brain Neoplasms [MESH:D001932] (2764) |
|
|
|
|
|
|
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
|
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Cerebral Hemorrhage [MESH:D002543] (2873) |
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Alzheimer Disease [MESH:D000544] (4275) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Status Epilepticus [MESH:D013226] (4014) |
|
|
Epilepsy, Temporal Lobe [MESH:D004833] (1108) |
|
|
|
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
|
|
|
Brain Neoplasms [MESH:D001932] (2764) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Alzheimer Disease [MESH:D000544] (4275) |
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
Seizures [MESH:D012640] (4514) |
|
|
Hyperkinesis [MESH:D006948] (1799) |
|
|
Memory Disorders [MESH:D008569] (3233) |
|
|
Learning Disorders [MESH:D007859] (2727) |
|
|
|
|
|
Hyperalgesia [MESH:D006930] (3929) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Arsenic Poisoning [MESH:D020261] (2540) |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
 |
C11. Eye Diseases |
 |
 |
|
C11. Eye Diseases |
|
|
|
|
|
Corneal Neovascularization [MESH:D016510] (622) |
|
|
Diabetic Retinopathy [MESH:D003930] (1371) |
|
|
Retinal Vein Occlusion [MESH:D012170] (607) |
|
|
|
|
|
Macular Edema [MESH:D008269] (557) |
|
|
|
|
|
Choroidal Neovascularization [MESH:D020256] (550) |
|
 |
C12. Male Urogenital Diseases |
 |
 |
|
C12. Male Urogenital Diseases |
|
|
|
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Erectile Dysfunction [MESH:D007172] (1791) |
|
|
|
|
|
Prostatic Neoplasms [MESH:D011471] (6135) |
|
|
Kidney Neoplasms [MESH:D007680] (3966) |
|
|
|
|
|
Diabetic Nephropathies [MESH:D003928] (2301) |
|
|
Kidney Neoplasms [MESH:D007680] (3966) |
|
|
Glomerulonephritis [MESH:D005921] (3758) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
 |
C13. Female Urogenital Diseases and Pregnancy Complications |
 |
 |
|
C13. Female Urogenital Diseases and Pregnancy Complications |
|
|
|
|
|
Endometriosis [MESH:D004715] (2461) |
|
|
|
|
|
Ovarian Neoplasms [MESH:D010051] (3281) |
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
|
|
|
|
Endometrial Neoplasms [MESH:D016889] (1984) |
|
|
|
|
|
Ovarian Neoplasms [MESH:D010051] (3281) |
|
|
Endometrial Neoplasms [MESH:D016889] (1989) |
|
|
Kidney Neoplasms [MESH:D007680] (3966) |
|
|
|
|
|
Diabetic Nephropathies [MESH:D003928] (2301) |
|
|
Kidney Neoplasms [MESH:D007680] (3966) |
|
|
Glomerulonephritis [MESH:D005921] (3758) |
|
|
Acute Kidney Injury [MESH:D058186] (4142) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
 |
C14. Cardiovascular Diseases |
 |
 |
|
C14. Cardiovascular Diseases |
|
|
|
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
Heart Failure [MESH:D006333] (4058) |
|
|
Hypertrophy, Right Ventricular [MESH:D017380] (136) |
|
|
Cardiomyopathy, Hypertrophic [MESH:D002312] (1516) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
|
|
|
Cardiomyopathy, Hypertrophic [MESH:D002312] (1451) |
|
|
|
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
Hypertension [MESH:D006973] (5655) |
|
|
Retinal Vein Occlusion [MESH:D012170] (607) |
|
|
|
|
|
Atherosclerosis [MESH:D050197] (4188) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
|
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Cerebral Hemorrhage [MESH:D002543] (2873) |
|
|
|
|
|
|
|
|
Infarction, Middle Cerebral Artery [MESH:D020244] (2268) |
|
|
Diabetic Retinopathy [MESH:D003930] (1371) |
|
|
|
|
|
|
|
|
Retinal Vein Occlusion [MESH:D012170] (607) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Coronary Artery Disease [MESH:D003324] (2685) |
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
 |
C15. Hemic and Lymphatic Diseases |
 |
 |
|
C15. Hemic and Lymphatic Diseases |
|
|
|
|
|
|
|
|
Thrombotic Microangiopathies [MESH:D057049] (2598) |
|
|
|
|
|
|
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
 |
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
 |
 |
|
C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
|
|
|
|
|
|
|
|
Costello Syndrome [MESH:D056685] (407) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
|
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
|
|
|
|
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
|
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Orofacial Cleft 10 [MESH:C566605] (39) |
|
|
Costello Syndrome [MESH:D056685] (407) |
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
|
|
|
|
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
Osteogenesis Imperfecta, Type IX [MESH:C564921] (46) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
 |
C17. Skin and Connective Tissue Diseases |
 |
 |
|
C17. Skin and Connective Tissue Diseases |
|
|
|
|
|
|
|
|
Osteogenesis Imperfecta, Type IX [MESH:C564921] (46) |
|
|
Noonan Syndrome 5 [MESH:C548083] (169) |
|
|
Arthritis, Rheumatoid [MESH:D001172] (3603) |
|
|
|
|
|
Chloracne [MESH:D054506] (1274) |
|
|
Breast Neoplasms [MESH:D001943] (6077) |
|
|
|
|
|
Dermatitis, Allergic Contact [MESH:D017449] (3241) |
|
|
|
|
|
Chloracne [MESH:D054506] (1274) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
LEOPARD syndrome, 2 [MESH:C537117] (169) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
|
|
|
Dermatitis, Allergic Contact [MESH:D017449] (3241) |
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
Psoriasis [MESH:D011565] (3278) |
|
 |
C18. Nutritional and Metabolic Diseases |
 |
 |
|
C18. Nutritional and Metabolic Diseases |
|
|
|
|
|
|
|
|
|
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
|
|
|
Diabetes Mellitus, Experimental [MESH:D003921] (4771) |
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
|
|
|
|
|
|
Pelizaeus-Merzbacher Disease [MESH:D020371] (103) |
|
|
|
|
|
|
|
|
Amyotrophic lateral sclerosis 1 [MESH:C531617] (2559) |
|
|
|
|
|
Obesity [MESH:D009765] (4462) |
|
 |
C19. Endocrine System Diseases |
 |
 |
|
C19. Endocrine System Diseases |
|
|
|
|
|
Diabetes Mellitus, Experimental [MESH:D003921] (4771) |
|
|
Diabetes Mellitus, Type 2 [MESH:D003924] (4219) |
|
|
Diabetic Nephropathies [MESH:D003928] (2301) |
|
|
Diabetic Retinopathy [MESH:D003930] (1371) |
|
|
Ovarian Neoplasms [MESH:D010051] (3275) |
|
|
Carcinoma, Pancreatic Ductal [MESH:D021441] (1056) |
|
|
|
|
|
Ovarian Neoplasms [MESH:D010051] (3281) |
|
|
Polycystic Ovary Syndrome [MESH:D011085] (2186) |
|
 |
C20. Immune System Diseases |
 |
 |
|
C20. Immune System Diseases |
|
|
|
|
|
Arthritis, Rheumatoid [MESH:D001172] (3601) |
|
|
|
|
|
Dermatitis, Allergic Contact [MESH:D017449] (3241) |
|
|
|
|
|
Asthma [MESH:D001249] (3914) |
|
|
Ectodermal Dysplasia, Anhidrotic, With T-Cell Immunodeficiency, Autosomal Dominant [MESH:C567411] (533) |
|
|
HIV Infections [MESH:D015658] (3402) |
|
|
|
|
|
|
|
|
Hodgkin Disease [MESH:D006689] (1082) |
|
 |
C22. Animal Diseases |
 |
 |
|
C22. Animal Diseases |
|
|
Mammary Neoplasms, Animal [MESH:D015674] (2735) |
|
 |
C23. Pathological Conditions, Signs and Symptoms |
 |
 |
|
C23. Pathological Conditions, Signs and Symptoms |
|
|
|
|
|
|
|
|
Hypertrophy, Right Ventricular [MESH:D017380] (136) |
|
|
Inflammation [MESH:D007249] (5241) |
|
|
Nerve Degeneration [MESH:D009410] (4061) |
|
|
Disease Progression [MESH:D018450] (2868) |
|
|
Genetic Predisposition to Disease [MESH:D020022] (966) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Shock, Hemorrhagic [MESH:D012771] (2042) |
|
|
Cerebral Hemorrhage [MESH:D002543] (2872) |
|
|
|
|
|
Choroidal Neovascularization [MESH:D020256] (550) |
|
|
Neoplasm Invasiveness [MESH:D009361] (3388) |
|
|
Neoplasm Metastasis [MESH:D009362] (4441) |
|
|
Cell Transformation, Neoplastic [MESH:D002471] (3389) |
|
|
|
|
|
Myocardial Reperfusion Injury [MESH:D015428] (3500) |
|
|
Shock, Hemorrhagic [MESH:D012771] (2042) |
|
|
|
|
|
|
|
|
Obesity [MESH:D009765] (4454) |
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
|
Seizures [MESH:D012640] (4502) |
|
|
Hyperkinesis [MESH:D006948] (1799) |
|
|
Memory Disorders [MESH:D008569] (3233) |
|
|
Learning Disorders [MESH:D007859] (2727) |
|
|
|
|
|
Hyperalgesia [MESH:D006930] (3929) |
|
|
Proteinuria [MESH:D011507] (3293) |
|
 |
C25. Chemically-Induced Disorders |
 |
 |
|
C25. Chemically-Induced Disorders |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Arsenic Poisoning [MESH:D020261] (2540) |
|
|
Drug-Induced Liver Injury [MESH:D056486] (4936) |
|
|
Neurotoxicity Syndromes [MESH:D020258] (3323) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2053) |
|
|
Amphetamine-Related Disorders [MESH:D019969] (2858) |
|
|
Cocaine-Related Disorders [MESH:D019970] (3054) |
|
|
Psychoses, Substance-Induced [MESH:D011605] (2052) |
|
|
Substance Withdrawal Syndrome [MESH:D013375] (2956) |
|
 |
C26. Wounds and Injuries |
 |
 |
|
C26. Wounds and Injuries |
|
|
Not Fully Specified [NFS] (2454) |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
|
Lung Injury [MESH:D055370] (1814) |
|
|
|
|
|
Brain Injuries [MESH:D001930] (3431) |
|
 |
D03. Heterocyclic Compounds |
 |
 |
|
D03. Heterocyclic Compounds |
|
|
|
|
|
Quinoxalines [MESH:D011810] (365) |
|
 |
E. Analytical, Diagnostic and Therapeutic Techniques and Equipment |
 |
 |
|
E. Analytical, Diagnostic and Therapeutic Techniques and Equipment |
|
|
|
|
|
|
|
|
|
|
|
Cardiofaciocutaneous syndrome [MESH:C535579] (407) |
|
 |